€1,496.08
€1,500
Aisling and Eve Oesophageal Cancer Fund (OCF)
Aisling and Eve
€1,496.08
€1,500
Oesophageal Cancer Fund (OCF)
Aisling and Eve
Aisling and Eve

Eve's page has now expired

246 days ago, Eve created this page in support of Oesophageal Cancer Fund (OCF).

With the help of Team OCF for Vhi Women's Mini Marathon 2018, Eve gave everything:

  • Shared their page with everyone they could.

  • Received 29 donations from generous family and friends.

  • Raised €1,496.08.

My Story

We have created this page because we want to make a difference. Eve suffers from Achalasia, a rare, currently incurable disease of the oesophagus that effects 1 in 100,000 people. Research into the oesophagus is so important and we’re inspired by the work of Oesophageal Cancer Fund (OCF) and wanted to support them by raising money as part of our participation in VHI Women's Mini Marathon 2018 as the work they do is so important. Please help us help them by giving whatever you can using the 'Give Now' button. The more people that know about Oesophageal Cancer Fund (OCF), the greater their impact, so please also spread the word by sharing our page with your friends and family. Thank you in advance for your generosity, it means a lot!

Team

Team OCF for Vhi Women's Mini Marathon 2018

Blob

Please support Team OCF at this year's Vhi Women's Mini Marathon and help raise the €25,000 required to meet our commitment in 2018 to fund the Irish costs of the Neo-AEGIS International Clinical Trial.

Professor John Reynolds, St. James's Hospital explains about this trial -

"The Oesophageal Cancer Fund (OCF) has worked since its inception to reduce the incidence and deaths from oesophageal cancer through prevention, early diagnosis and improving cure rates. Once a patient is diagnosed with oesophageal cancer, usually presenting through difficulty in swallowing, achieving a cure is notoriously difficult, with a cure rate of approximately 40 per cent. Clinical trials of new drugs and radiation therapy in combination with surgery offer the greatest promise to improve prognosis and cure rates. A major trial, NeoAEGIS, led by Irish investigators, is currently active and will include approximately 250 Irish patients in a trial of over 600 patients from major European specialist centres. The trial offers rich potential to improve cure rates, and to make new discovery from associated scientific research, and has attracted worldwide attention to date, as the outcome of the study is anticipated to transform care and outcomes for oesophageal cancer patients. The OCF is a proud supporter and part sponsor of the trial which is administered through Cancer Trials Ireland "

If you can't take part this year, you can still support by giving whatever you can using the 'Give Now' button on one of the supporter pages below. Please also spread the word by sharing our page with your friends and family and help us reach our goal so we can continue to support our research and really make a difference.

Thank you in advance for your generosity, it means a lot!

Visit Team
Team

Team OCF for Vhi Women's Mini Marathon 2018

Blob

Please support Team OCF at this year's Vhi Women's Mini Marathon and help raise the €25,000 required to meet our commitment in 2018 to fund the Irish costs of the Neo-AEGIS International Clinical Trial.

Professor John Reynolds, St. James's Hospital explains about this trial -

"The Oesophageal Cancer Fund (OCF) has worked since its inception to reduce the incidence and deaths from oesophageal cancer through prevention, early diagnosis and improving cure rates. Once a patient is diagnosed with oesophageal cancer, usually presenting through difficulty in swallowing, achieving a cure is notoriously difficult, with a cure rate of approximately 40 per cent. Clinical trials of new drugs and radiation therapy in combination with surgery offer the greatest promise to improve prognosis and cure rates. A major trial, NeoAEGIS, led by Irish investigators, is currently active and will include approximately 250 Irish patients in a trial of over 600 patients from major European specialist centres. The trial offers rich potential to improve cure rates, and to make new discovery from associated scientific research, and has attracted worldwide attention to date, as the outcome of the study is anticipated to transform care and outcomes for oesophageal cancer patients. The OCF is a proud supporter and part sponsor of the trial which is administered through Cancer Trials Ireland "

If you can't take part this year, you can still support by giving whatever you can using the 'Give Now' button on one of the supporter pages below. Please also spread the word by sharing our page with your friends and family and help us reach our goal so we can continue to support our research and really make a difference.

Thank you in advance for your generosity, it means a lot!

Visit Team

Thank You

Top Supporters
Show more Top Supporters Hide

Donations Summary

Open uri20170419 6 1yxtg67
Charity

Oesophageal Cancer Fund (OCF)